GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q1 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,007,000 | -0.1% | 23,130 | 0.0% | 0.92% | +1.4% |
| Q1 2022 | $1,008,000 | -13.8% | 23,130 | -12.7% | 0.91% | +14.8% |
| Q4 2021 | $1,169,000 | +15.4% | 26,500 | 0.0% | 0.79% | -8.3% |
| Q3 2021 | $1,013,000 | -4.0% | 26,500 | 0.0% | 0.86% | +13.5% |
| Q2 2021 | $1,055,000 | +11.5% | 26,500 | 0.0% | 0.76% | +5.7% |
| Q1 2021 | $946,000 | +5.0% | 26,500 | +19.4% | 0.72% | -1.4% |
| Q3 2017 | $901,000 | -5.9% | 22,200 | 0.0% | 0.73% | -11.4% |
| Q2 2017 | $957,000 | +2.2% | 22,200 | 0.0% | 0.82% | -1.1% |
| Q1 2017 | $936,000 | +9.5% | 22,200 | 0.0% | 0.83% | +38.6% |
| Q4 2016 | $855,000 | – | 22,200 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |